|
Shapira et al. (2016)
|
21 |
CNC (11) |
ANG (10) |
0, 30, and 90 days |
No statistically significant difference in latency (1.39 ms vs. 1.63 ms; p=0.48) and amplitude (6.28 mv vs. 6.43 mv; p=0.8) |
No difference in number and size of myelinated fibers |
No difference between groups (P = 0.177) |
|
Azizi et al. (2014)
|
90 |
CNC + Vit E (15); CNC + PQQ (15); CNC + PQQ + Vit E (15); CNC (15) |
TC (15); Sham (15) |
4, 8, and 12 weeks |
% of sciatic conduction velocity recovery: (A) 42% (B) 34% (C) 54%; 17% in group D (p < 0.05); <10% in control group |
Groups A, B, and C presented greater nerve fiber, axon diameter, and myelin sheath thickness |
Experimental groups had greater SFI than TC in all evaluations |
|
Ilkhanizadeh et al. (2017)
|
60 |
CNC + BMMC (15) |
Sham (15); nerve suture (15); CNC + saline (15) |
4, 8, and 12 weeks |
Not evaluated |
Rats treated with BMMC had significantly greater nerve fiber, axon diameter, and myelin sheath thickness |
At 12 weeks: mean SFI in CNC + BMMC: ~-17.5 versus –26 in CNC + saline group (p < 0.05) |
|
Dietzmeyer et al. (2019)
|
32 |
Two-chambered CNC (8); Two-chambered corrugated CNC (8) |
Standard CNC (8); ANG (8) |
16 weeks |
Full recovery in C2. CMAPs: no difference in treated rats compared to controls after 16 weeks. Higher amplitudes obtained in C2 group |
C1 and C2 showed thicker tissue cables and higher number of regrown axons within the distal graft compared to groups A and B |
Not evaluated |
|
Liu et al. (2019)
|
150 |
Chitosan only (30); Chitosan + mPEG-PELG (30); Chitosan + NGF/IM (30); Chitosan/mPEG-PELG (30) |
ANG (30) |
12 and 24 weeks |
ANG and group D association had higher CMAP amplitude and motor NCV than other groups |
Group D showed greater number of regenerating fibers and thickness of myelin sheath than A, B, and C, but comparable results to ANG group |
Rats in group D achieved a superior SFI. No statistical difference with the control group |
|
Azizi et al. (2015)
|
45 |
CNC with alpha-lipoic acid (15) |
CNC + saline solution (15); Sham (15) |
4, 8, and 12 weeks |
NCV at 12 weeks (group A vs B): 39% ± 1.8% vs 26.5% (P < 0.05); recovery index at 12 weeks: 0.29 ± 0.02 vs 0.25 ± 0.03 (p <0.05) |
Group A showed greater nerve fibers and axon diameter, and myelin sheath thickness than control group (P < 0.05) at 8 and 12 weeks |
Functional recovery assessed through SFI was faster in experimental group at 4 and 8 weeks after surgery |
|
Raisi et al. (2012)
|
60 |
CNC (15) |
Silicone conduit (15); Sham (15); TCI (15) |
4, 8, and 12 weeks |
NCV at 12 weeks in experimental groups were higher than in control. Group A: 28% vs 28.5% in group B. Transected control: 4% (p < 0.05) |
The number of nerve fibers and mean diameter of fibers in experimental group were higher than in TC group |
Better SFI for rats in group A than in control (p < 0.05) |
|
Carvalho et al. (2018)
|
26 |
CNCs (19) |
ANG (7) |
12 weeks |
ANG showed increased recovery with 100% and 71% evocable CMAPs from tibialis anterior and plantar muscles. Only 5 animals from CNC groups displayed evocable CMAPs |
ANG displayed thick and complete nerve bridge. CNC 25:75 displayed thin but continuous nerve cable |
Not evaluated |
|
Duda et al. (2014)
|
36 |
COM (12); CNC (12) |
ANG (12); ANG (long term) (17) |
2 and 13 weeks |
No statistically significant intergroup differences. ANG had highest CMAP amplitude followed by CNC and COM. NCV ratio significantly reduced for COM compared to ANG |
Nerve fiber density significantly higher in ANG group. Artificial grafts comparable to ANG in myelin thickness |
Not evaluated |
|
Haastert-Talini et al. (2013)
|
141 |
DAI (17); DAII (17); DAIII (17) |
ANG |
13 weeks |
No significant differences among amplitudes of evocable CMAPs between groups |
Only total numbers of myelinated fibers distal from DAI significantly higher compared to ANG group (p<0.05). No statistical differences in axon and fiber diameters and myelin thickness |
Not evaluated |
|
Sun et al. (2024)
|
24 |
Curcumin in keratin-chitosan hydrogels (12) |
ANG (12) |
10, 30, and 90 days |
Not evaluated |
Increase in myelin sheath thickness, higher number of myelinated fibers |
Significant improvement in SFI |
|
Zhang et al. (2024)
|
30 |
Alginate microgels with VEGF and BDNF + chitosan conduits (15) |
Control (15) |
12 weeks |
Significant increase in CMAP amplitude (p < 0.05) |
Increase in myelin thickness and axon diameter |
SFI improved at all evaluated times |
|
Jafarisavari et al. (2024)
|
25 |
PCL-chitosan nanofibrous conduits with piracetam and vitamin B12 (15) |
ANG (10) |
4, 8, and 12 weeks |
Not evaluated |
Larger axonal diameter and myelin thickness compared to control |
SFI significantly improved (p < 0.05) |
|
Al-Haideri and Al-Timmemi (2024)
|
28 |
Chitosan conduits with nanoparticles (14) |
Control (14) |
56 and 112 days |
Increase in NCV compared to control (p < 0.05) |
Increase in myelin thickness and number of myelinated fibers |
SFI improved compared to control |
|
Xue et al. (2024)
|
40 |
Skin-derived precursors induced into Schwann cells + chitosan/silk conduits (20) |
Control (20) |
90 days |
Not evaluated |
Increase in axon number and myelin sheath thickness |
SFI significantly improved compared to control (p < 0.05) |
|
Li et al. (2024)
|
30 |
Chitosan conduits with BDNF (15) |
ANG (15) |
12 weeks |
Increase in CMAP amplitude (p < 0.05) |
Increase in myelin thickness and axon diameter compared to control |
SFI significantly improved (p < 0.05) |
|
Zhang et al. (2023)
|
35 |
Nanofibrous scaffolds containing chitosan, ADSCs, and NGF (20) |
Control (15) |
5 weeks |
Increase in NCV and CMAP (p < 0.05) |
Increase in myelin sheath thickness and axon diameter |
SFI improved compared to control |
|
Jiang et al. (2023)
|
25 |
O-carboxymethyl chitosan conduits (13) |
ANG (12) |
10, 30, and 90 days |
Not evaluated |
Increase in myelin sheath thickness, higher number of myelinated fibers |
Significant improvement in SFI |
|
Qi et al. (2023)
|
24 |
Bionic chitosan graft (12) |
Control (12) |
4, 8, and 12 weeks |
Not evaluated |
Larger axonal diameter and myelin thickness compared to control |
SFI significantly improved (p < 0.05) |
|
Wang et al. (2023)
|
28 |
Chitosan scaffold with esterase release (14) |
Control (14) |
56 and 112 days |
Increase in NCV compared to control (p < 0.05) |
Increase in myelin thickness and number of myelinated fibers |
SFI improved compared to control |
|
Li et al. (2023)
|
28 |
Sustained release microspheres of NGF and BDNF in chitosan conduits (14) |
Control (14) |
56 and 112 days |
Increase in NCV compared to control (p < 0.05) |
Increase in myelin thickness and number of myelinated fibers |
SFI improved compared to control |